What Is Metformin?
Metformin (metformin hydrochloride) is a biguanide medication and the most widely recommended first-line oral therapy for adults with type 2 diabetes globally. It has been in clinical use since 1957 in the UK and 1995 in the US, with an evidence base built over more than six decades. It works by reducing the glucose your liver releases and improving how your body responds to insulin, without causing the pancreas to make more insulin. That means it carries a low risk of low blood sugar when used on its own.
How Metformin Works
Liver FunctionReduces hepatic glucose output, the primary mechanism that lowers fasting blood sugar.
Insulin SensitivityImproves how muscles and fat tissue respond to insulin, helping cells take up glucose more efficiently.
Gut AbsorptionSlows intestinal glucose absorption and may influence gut-derived signals that affect appetite and metabolic function.
Low Hypoglycemia RiskDoes not directly stimulate insulin secretion, so it rarely causes dangerously low blood sugar when taken alone.
Metformin for PCOS
PCOS is one of the most common off-label uses of metformin. Because PCOS is strongly associated with insulin resistance, metformin can help by improving insulin sensitivity, which may regulate menstrual cycles, reduce androgen levels, and improve ovulation. While metformin is not FDA-approved for PCOS, it is widely used for this purpose per major endocrinology guidelines.
Metformin for Prediabetes
The Diabetes Prevention Program trial (3,234 adults) showed that metformin reduced the risk of developing type 2 diabetes by 31% over 2.8 years. It was especially effective for younger, heavier individuals and remained beneficial at 15-year follow-up. Clinicians may prescribe metformin for prediabetes patients at high risk who have not responded adequately to lifestyle changes alone.
Metformin Clinical Evidence (UKPDS and DPP)
Metformin's safety and effectiveness are supported by decades of large-scale clinical trials. The UKPDS is one of the longest and most influential diabetes studies ever conducted.
UKPDS: United Kingdom Prospective Diabetes Study
4,075 newly diagnosed type 2 diabetes patients, 23 UK centres, median 10-year follow-up. In the overweight subgroup treated with metformin:
- 36% reduction in all diabetes-related endpoints vs conventional therapy
- 33% reduction in heart attack risk
- 42% reduction in diabetes-related death
- 0.9% average A1C reduction from baseline
Metformin A1C Outcomes by Dose
| Daily Dose | Typical A1C Reduction | Notes |
| 500 to 1000mg/day | 0.5 to 0.8% | Starting or low doses. GI side effects often manageable here. |
| 1500 to 2000mg/day | 0.9 to 1.5% | Common therapeutic range. Most trial data at this dose. |
| 2500mg/day | Up to 1.8% | Maximum recommended dose. Minimal extra benefit above 2000mg for most patients. |
Metformin Dosing and How to Take It
Standard Dose Escalation
| Timeframe | Typical Dose | Purpose |
| Weeks 1 to 2 | 500mg once daily with dinner | Starter dose to minimize GI side effects. |
| Weeks 3 to 4 | 500mg twice daily | With breakfast and dinner if tolerated. |
| Maintenance | 1000 to 2000mg/day | Most clinical data at this range. Split across meals. |
| Maximum | 2550mg/day | Rarely needed. Minimal extra benefit above 2000mg. |
Immediate Release vs Extended Release
| Form | How Taken | GI Tolerance | Strengths |
| Immediate release (IR) | 2 to 3 times daily with meals | More GI side effects, take with food | 500mg, 750mg, 850mg, 1000mg |
| Extended release (XR/ER) | Once daily with evening meal | Better GI tolerance, fewer stomach effects | 500mg, 750mg, 1000mg |
Key tips: Always take with food to reduce nausea. Start low and increase gradually. If you miss a dose, take it with your next meal. Never double dose. Hold metformin before contrast dye procedures as directed by your clinician. You may be asked to stop 48 hours before general anesthesia.
Important Safety Information for Metformin
This is not a complete list. Always review the full Prescribing Information and speak with a licensed clinician.
Do Not Take Metformin If:
- You have severe kidney disease or significantly reduced kidney function (eGFR below 30).
- You have acute or chronic metabolic acidosis, including diabetic ketoacidosis.
- You are scheduled for imaging with iodinated contrast dye (hold as directed).
- You are allergic to metformin or any of its ingredients.
Lactic Acidosis
Lactic acidosis is rare but serious, especially in people with kidney, liver, or heart problems, or during dehydration, infection, or heavy alcohol use. Symptoms include unusual fatigue, muscle pain, rapid breathing, stomach pain, or feeling cold, dizzy, or confused. Seek emergency care immediately if you experience these.
Common Side Effects
Nausea, diarrhea, stomach upset, gas, and a metallic taste. These are most common when starting or increasing the dose. Taking metformin with food and using gradual dose escalation significantly reduces these effects. Extended-release formulations may be better tolerated.
Vitamin B12 Monitoring
Long-term metformin use may reduce vitamin B12 absorption. Your clinician may check B12 levels periodically and recommend supplementation if needed.
Metformin vs GLP-1 Medications
Metformin is usually the foundation of type 2 diabetes care. Depending on your A1C, weight goals, cardiovascular history, and insurance, your prescriber may add or switch to other medications.
| Feature | Metformin | Ozempic | Mounjaro |
| Class | Biguanide | GLP-1 agonist | Dual GIP/GLP-1 |
| A1C reduction | 0.9 to 1.5% | 1.5 to 1.9% | 2.0 to 2.3% |
| Weight effect | Modest loss or neutral | 4.5 to 6 kg loss | Up to 22.5% body weight |
| How taken | Oral, 1 to 3x daily | Injection, once weekly | Injection, once weekly |
Can I Take Metformin with GLP-1 Medications?
Yes. Metformin is commonly prescribed alongside Ozempic, Wegovy, or Mounjaro. The combination provides complementary mechanisms: metformin addresses liver glucose output and insulin sensitivity, while GLP-1 medications add appetite control, additional A1C reduction, and weight loss benefits.
Frequently Asked Questions About Metformin